---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-008489"
form_type: "8-K"
ticker: "OGEN"
cik: "0001174940"
company_name: "ORAGENICS INC"
filed_at: "2024-03-01T23:59:59+00:00"
generated_at: "2026-06-05T05:18:09.280737+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Oragenics closes $2.1M public offering of 1.4M shares; funds ONP-002 development

## Summary
- Issued 1,400,000 shares at $1.50/share for gross proceeds of $2.1M.
- Underwriters granted a 45-day option for up to 210,000 additional shares.
- Net proceeds to fund continued development of ONP-002 for concussion treatment.
- Representative's warrants issued for up to 5% of Shares at $1.875/share.

## SEC filing metadata
- accession: 0001493152-24-008489
- form_type: 8-K
- ticker: OGEN
- cik: 0001174940
- company_name: ORAGENICS INC
- filed_at: 2024-03-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1174940/000149315224008489/0001493152-24-008489-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1174940/000149315224008489/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-008489
- JSON: https://secwatch.observer/filing/0001493152-24-008489.json
- Plain text: https://secwatch.observer/filing/0001493152-24-008489.txt

## Key facts
- Material Agreements
  ORAGENICS INC entered into Underwriting Agreement with ThinkEquity LLC valued at $2.1 million (effective 2024-02-27).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: ThinkEquity LLC
  - Value: $2.1 million
  - Effective: 2024-02-27
  source text: On February 27, 2024, Oragenics, Inc. (“Oragenics” or the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with ThinkEquity LLC, as representative (the “Representative”) of the underwriters named therein (collectively, the “Underwriters”), relating to the issuance and sale (the “Offering”) of 1,400,000 shares of the Company’s common stock at a price to the public of $1.50 per share (the “Underwritten Shares”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1174940/000149315224008489/0001493152-24-008489-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.